Roth/MKM analyst Max Masucci initiates coverage on Rapid Micro Biosystems Inc (NASDAQ: RPID) with a Buy rating and a price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage